Cargando…
Dyslipidemia, Diabetes and Atherosclerosis: Role of Inflammation and ROS-Redox-Sensitive Factors
The prevalence of diabetes is growing at an alarming rate with increased disability, morbidity, and often premature mortality because of the various complications of this disorder. Chronic hyperglycemia, dyslipidemia, and other metabolic alterations lead to the development and progression of macro-...
Autores principales: | Hasheminasabgorji, Elham, Jha, Jay C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615779/ https://www.ncbi.nlm.nih.gov/pubmed/34829831 http://dx.doi.org/10.3390/biomedicines9111602 |
Ejemplares similares
-
Atherosclerosis, Dyslipidemia, and Inflammation: The Significant Role of Polyunsaturated Fatty Acids
por: Dessì, Mariarita, et al.
Publicado: (2013) -
High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation
por: Lechner, Katharina, et al.
Publicado: (2020) -
Recent Advances in ROS-Sensitive Nano-Formulations for Atherosclerosis Applications
por: Ji, Hao, et al.
Publicado: (2021) -
TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis
por: Zysset, Daniel, et al.
Publicado: (2016) -
The redox-sensitive cation channel TRPM2 modulates phagocyte ROS production and inflammation
por: Di, Anke, et al.
Publicado: (2011)